• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6801325
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/20/2023
Event Type  malfunction  
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report discordant, non-reactive vitros ahcv results were obtained when samples from multiple patients were tested on a vitros xt7600 integrated system.The results were discordant when compared to reactive non-vitros method results for the same patient samples.Vitros ahcv results: patient 6, vitros ahcv results of 0.68 and 0.70 s/c (non-reactive) vs the expected result of reactive patient 7, vitros ahcv result of 0.82 s/c (non-reactive) vs the expected result of reactive patient 9, vitros ahcv result of 0.79 s/c (non-reactive) vs the expected result of reactive patient 10, vitros ahcv results of 0.06 and 0.08 s/c (non-reactive) vs the expected result of reactive patient 11, vitros ahcv results of 0.02 and 0.04 s/c (non-reactive) vs the expected result of reactive patient 12, vitros ahcv results of 0.5 and 0.59 s/c (non-reactive) vs the expected result of reactive patient 13, vitros ahcv results of 0.68 and 0.70 s/c (non-reactive) vs the expected result of reactive biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The discordant, false non-reactive/negative vitros results were not reported from the laboratory as the patient samples were tested as part of the validation of a vitros instrument.Ortho has not been made aware of any allegation of patient harm as a result of this event.This report is number one of two mdr¿s for this event.Two 3500a forms are being submitted for this event as two devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).And reportability assessment (b)(4).
 
Manufacturer Narrative
The investigation determined that discordant, non-reactive vitros ahcv results were obtained when samples from multiple patients were tested on a vitros xt7600 integrated system.The results were discordant when compared to reactive non-vitros method results for the same patient samples.A definitive cause of the event was not determined with the limited information provided.The discordant, non-reactive vitros results were obtained on a vitros xt7600 integrated system undergoing validation at the customer site and the vitros ahcv reagent assay had recently been put into use on the instrument, therefore, there were no historical qcs to verify the performance of the assay.However, qc results around the time of patient sample testing were acceptable, suggesting acceptable vitros ahcv lot 5320 performance.Additionally, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros ahcv lot 5320.An instrument issue cannot be ruled out as a contributor to the event as there was no indication diagnostic precision testing had been conducted around the time the discordant, non-reactive vitros results were obtained.A potential cause of the event is the stability of the patient samples tested.The patient samples were tested following being stored at prolonged periods at -20°c and the ortho ls questioned the integrity of the patient samples tested.For certain samples, historical testing had occurred as far back as 2008.In addition, certain samples were turbid and turbid samples should not be used for vitros ahcv testing.The ortho tsc recommended further correlation testing to be conducted using patient samples within the stability as per the vitros instructions for use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS, INC.
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
microtyping systems
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key16572102
MDR Text Key312285498
Report Number3007111389-2023-00043
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
Reporter Country CodeHR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/09/2023
Device Catalogue Number6801325
Device Lot Number5320
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/20/2023
Initial Date FDA Received03/20/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/12/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-